Show simple item record

The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients

dc.contributor.authorBasaran, G.
dc.contributor.authorSaglam, S.
dc.contributor.authorTansan, S.
dc.contributor.authorDemirel, M.
dc.contributor.authorGokmen, E.
dc.contributor.authorAktan, S.
dc.contributor.authorGoker, E.
dc.contributor.authorKaban, K. K.
dc.contributor.authorSaip, P.
dc.contributor.authorDemir, G.
dc.contributor.authorBavbek, S. E.
dc.contributor.authorMandel, N. M.
dc.contributor.authorTecimer, C.
dc.contributor.authorTurhal, N. S.
dc.contributor.authorGaripoglu, M.
dc.date.accessioned2021-03-05T17:24:42Z
dc.date.available2021-03-05T17:24:42Z
dc.date.issued2011
dc.identifier.citationBasaran G., Saglam S., Tansan S., Demirel M., Gokmen E., Aktan S., Goker E., Kaban K. K. , Saip P., Demir G., et al., "The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients", JOURNAL OF CLINICAL ONCOLOGY, cilt.29, 2011
dc.identifier.issn0732-183X
dc.identifier.othervv_1032021
dc.identifier.otherav_c56b2b73-a983-428b-a5e8-fdf1a884de4d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/130897
dc.identifier.urihttps://doi.org/10.1200/jco.2011.29.15_suppl.e11042
dc.language.isoeng
dc.subjectONKOLOJİ
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleThe impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume29
dc.identifier.issue15
dc.contributor.firstauthorID200420


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record